210 filings
Page 5 of 11
8-K
7t5pwq4s
18 Oct 21
Departure of Directors or Certain Officers
8:05am
8-K
8yp0aicgf8hj 4l75qdo
5 Aug 21
Kala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
7:01am
CT ORDER
sbt9b5qsjrx07
15 Jul 21
Confidential treatment order
12:00am
8-K
lyrpizt
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
o6p1km8p5s7
5 May 21
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:04am
8-K
45a5kr7
5 May 21
Entry into a Material Definitive Agreement
7:00am
DEFA14A
jwav0ioi
28 Apr 21
Additional proxy soliciting materials
8:03am
S-8
0qy4d2ka
25 Feb 21
Registration of securities for employees
4:10pm
8-K
gys m91o2
25 Feb 21
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
7:01am
8-K
nxrfs9
7 Jan 21
Results of Operations and Financial Condition
7:02am
8-K
c22wbq rl
5 Nov 20
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:01am
8-K
r3obpatr7ugi6q72
27 Oct 20
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
7:03am
8-K
rilwbxznxksc8cbmcn9
17 Sep 20
Regulation FD Disclosure
7:30am
8-K
ypwjt6v31pruhyy t7
6 Aug 20
Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:05am